Literature DB >> 21470202

The role of perivascular adipose tissue in vascular smooth muscle cell growth.

Chao-Yu Miao1, Zhi-Yong Li.   

Abstract

UNLABELLED: Adipose tissue is the largest endocrine organ, producing various adipokines and many other substances. Almost all blood vessels are surrounded by perivascular adipose tissue (PVAT), which has not received research attention until recently. This review will discuss the paracrine actions of PVAT on the growth of underlying vascular smooth muscle cells (VSMCs). PVAT can release growth factors and inhibitors. Visfatin is the first identified growth factor derived from PVAT. Decreased adiponectin and increased tumour necrosis factor-α in PVAT play a pathological role for neointimal hyperplasia after endovascular injury. PVAT-derived angiotensin II, angiotensin 1-7, reactive oxygen species, complement component 3, NO and H(2) S have a paracrine action on VSMC contraction, endothelial or fibroblast function; however, their paracrine actions on VSMC growth remain to be directly verified. Factors such as monocyte chemoattractant protein-1, interleukin-6, interleukin-8, leptin, resistin, plasminogen activator inhibitor type-1, adrenomedullin, free fatty acids, glucocorticoids and sex hormones can be released from adipose tissue and can regulate VSMC growth. Most of them have been verified for their secretion by PVAT; however, their paracrine functions are unknown. Obesity, vascular injury, aging and infection may affect PVAT, causing adipocyte abnormality and inflammatory cell infiltration, inducing imbalance of PVAT-derived growth factors and inhibitors, leading to VSMC growth and finally resulting in development of proliferative vascular disease, including atherosclerosis, restenosis and hypertension. In the future, using cell-specific gene interventions and local treatments may provide definitive evidence for identification of key factor(s) involved in PVAT dysfunction-induced vascular disease and thus may help to develop new therapies. LINKED ARTICLES: This article is part of a themed section on Fat and Vascular Responsiveness. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue-3.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Year:  2012        PMID: 21470202      PMCID: PMC3315037          DOI: 10.1111/j.1476-5381.2011.01404.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  180 in total

1.  Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion.

Authors:  Yu-Jing Gao; Kumiko Takemori; Li-Ying Su; Wen-Sheng An; Chao Lu; Arya M Sharma; Robert M K W Lee
Journal:  Cardiovasc Res       Date:  2006-03-21       Impact factor: 10.787

2.  Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: results of a randomized longitudinal trial.

Authors:  Domingos S R Souza; Benny Johansson; Leif Bojö; Roland Karlsson; Håkan Geijer; Derek Filbey; Lennart Bodin; Mikael Arbeus; Michael R Dashwood
Journal:  J Thorac Cardiovasc Surg       Date:  2006-08       Impact factor: 5.209

3.  Adiponectin produced in coronary circulation regulates coronary flow reserve in nondiabetic patients with angiographically normal coronary arteries.

Authors:  Haruhiko Date; Takuroh Imamura; Takeshi Ideguchi; Junji Kawagoe; Takahiro Sumi; Hiroyuki Masuyama; Hisamitsu Onitsuka; Tetsunori Ishikawa; Toshiro Nagoshi; Tanenao Eto
Journal:  Clin Cardiol       Date:  2006-05       Impact factor: 2.882

4.  Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II- and endothelin-1-dependent mechanisms and mediates stretch-induced hypertrophy.

Authors:  Asad Zeidan; Daniel M Purdham; Venkatesh Rajapurohitam; Sabzali Javadov; Subrata Chakrabarti; Morris Karmazyn
Journal:  J Pharmacol Exp Ther       Date:  2005-09-06       Impact factor: 4.030

5.  Interleukin-6 upregulates expression of KDR and stimulates proliferation of human cerebrovascular smooth muscle cells.

Authors:  Jianhua S Yao; Wenwu Zhai; Yongfeng Fan; Michael T Lawton; Nicholas M Barbaro; William L Young; Guo-Yuan Yang
Journal:  J Cereb Blood Flow Metab       Date:  2006-07-05       Impact factor: 6.200

6.  Gene organization, alternate splicing and expression pattern of porcine visfatin gene.

Authors:  Huaping Chen; Tao Xia; Lei Zhou; Xiaodong Chen; Li Gan; Wenshu Yao; Yin Peng; Zaiqing Yang
Journal:  Domest Anim Endocrinol       Date:  2006-04-18       Impact factor: 2.290

7.  Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?

Authors:  Elvire Henrichot; Cristiana E Juge-Aubry; Agnès Pernin; Jean-Claude Pache; Valdimir Velebit; Jean-Michel Dayer; Paolo Meda; Carlo Chizzolini; Christoph A Meier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-09-29       Impact factor: 8.311

8.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

9.  Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.

Authors:  Yabing Chen; Ralph C Budd; Robert J Kelm; Burton E Sobel; David J Schneider
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-05-18       Impact factor: 8.311

Review 10.  The (pro)renin receptor: pathophysiological roles in cardiovascular and renal pathology.

Authors:  Geneviève Nguyen
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-03       Impact factor: 2.894

View more
  48 in total

1.  Obesity and vascular dysfunction: the fat-e of rich and poor.

Authors:  Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 2.  Association between Bacterial Infection and Peripheral Vascular Disease: A Review.

Authors:  Jacek Budzyński; Joanna Wiśniewska; Marek Ciecierski; Anna Kędzia
Journal:  Int J Angiol       Date:  2015-03-23

3.  Adipose phenotype predicts early human autogenous arteriovenous hemodialysis remodeling.

Authors:  Christine R Mauro; Kui Ding; Hui Xue; Ming Tao; Alban Longchamp; Michael Belkin; Bruce S Kristal; C Keith Ozaki
Journal:  J Vasc Surg       Date:  2014-09-26       Impact factor: 4.268

Review 4.  Perivascular adipose tissue: epiphenomenon or local risk factor?

Authors:  K Schäfer; I Drosos; S Konstantinides
Journal:  Int J Obes (Lond)       Date:  2017-05-22       Impact factor: 5.095

Review 5.  Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.

Authors:  Takayuki Matsumoto; Styliani Goulopoulou; Kumiko Taguchi; Rita C Tostes; Tsuneo Kobayashi
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

Review 6.  'Adipaging': ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue.

Authors:  Laura M Pérez; Helios Pareja-Galeano; Fabián Sanchis-Gomar; Enzo Emanuele; Alejandro Lucia; Beatriz G Gálvez
Journal:  J Physiol       Date:  2016-05-10       Impact factor: 5.182

7.  Proliferation and differentiation of human adipose-derived mesenchymal stem cells (ASCs) into osteoblastic lineage are passage dependent.

Authors:  Jiovanni A Di Battista; Wassim Shebaby; Ozge Kizilay; Eva Hamade; Raghida Abou Merhi; Saida Mebarek; Dina Abdallah; Bassam Badran; Fady Saad; Eddie K Abdalla; Wissam H Faour
Journal:  Inflamm Res       Date:  2014-08-07       Impact factor: 4.575

Review 8.  Proinflammatory phenotype of perivascular adipocytes.

Authors:  Abdullah Omar; Tapan K Chatterjee; Yaoliang Tang; David Y Hui; Neal L Weintraub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-12       Impact factor: 8.311

9.  Longitudinal Associations of Pericardial and Intrathoracic Fat With Progression of Coronary Artery Calcium (from the Framingham Heart Study).

Authors:  Jane J Lee; Alison Pedley; Udo Hoffmann; Joseph M Massaro; Christopher J O'Donnell; Emelia J Benjamin; Michelle T Long
Journal:  Am J Cardiol       Date:  2017-10-19       Impact factor: 2.778

Review 10.  Innate immune activation in obesity.

Authors:  Carey N Lumeng
Journal:  Mol Aspects Med       Date:  2012-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.